Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorXuanwu Hospital, Beijing
About this trial
The goal of this clinical trial is to learn about the application of domestic PET/MR in major brain diseases. The main questions it aims to answer are:
* Overcome the bottleneck of early accurate diagnosis and treatment in major brain diseases clinical practice. * Promote the clinical application of domestic PET/MR, enhance international competitiveness. Participants will have a PET/MR scan of the brain.
Eligibility criteria
Qualifiers
Patients diagnosed with mild cognitive impairment (MCI) or Alzheimer's disease (AD), rapid eye movement sleep behavior disorder (RBD) or Parkinson's disease (PD), epilepsy, malignant brain tumors based on clinical guidelines.
Patients admitted to our hospital for inpatient treatment.
Disqualifiers
Patients who have undergone non-invasive/minimally invasive treatments such as radiotherapy or chemotherapy within the past three weeks. And Patients who have taken Alzheimer's disease-related and Parkinson's disease-related treatment drugs within the past month.
Patients with persistent seizures or status epilepticus that cannot be controlled by medication, resulting in an inability to cooperate with the examination.
patients with poorly controlled blood sugar and ineffective medication intervention.
Patients with absolute contraindications for PET/MR examination.
Trial design
Treatments tested in this trial
- PET/MR
Treatment groups
2,300 Participants
are divided into 4 treatment groupsSponsors and collaborators
Xuanwu Hospital, Beijing
Lead sponsor
Peking University Cancer Hospital & Institute
Collaborator
Shanghai Zhongshan Hospital
Collaborator
Wuhan TongJi Hospital
Collaborator
Henan Provincial People's Hospital
Collaborator
Sun Yat-sen University
Collaborator
Shanghai East Hospital of Tongji University
Collaborator
The First Affiliated Hospital with Nanjing Medical University
Collaborator
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Collaborator
Shanghai Jiao Tong University School of Medicine
Collaborator
Source ClinicalTrials.gov